Ameris Bancorp

ABCBNYSEUSD

THESIS ALERT

Email me when the ABCB thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$82.96
+$0.02 (+0.02%)Today 1M +4.96%
After hours$83.44+0.58%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$82.94
Prior regular-session close from the quote source.
$82.07–$83.43
Regular-session low and high so far today.
316.0K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$69.58–$93.22
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own ABCB if it sustains deposit-funded loan growth and preserves net interest margin while using rising book equity to deploy capital (organic lending, M&A, buybacks) to raise ROE and EPS.

ABCB price history

Latest price$82.96Today+$0.02 (+0.02%)
ABCB +4.29%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Ameris will continue to translate asset growth and favorable loan/fee pricing into rising GAAP net income provided deposit funding and credit performance remain stable.StrengtheningMateriality: High

    net_income increased from 358,685,000 (FY2024) to 412,154,000 (FY2025). If true, shareholders get rising earnings and EPS without sacrificing capital; if false, margins and profitability will decay and valuation will compress.

    Watch: large deposit outflows forcing reliance on wholesale funding and higher funding costs (competitive pressure from national banks/fintechs).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    net_income increased from 358,685,000 (FY2024) to 412,154,000 (FY2025).

    Open source ↗
  • Core deposit stability and prudent liquidity management will fund loan growth and protect margins, which shows up in positive operating cash flow and stable cash balances.HoldingMateriality: High

    operating_cash_flow turned positive and grew from 154,193,000 (FY2024) to 390,183,000 (FY2025). Stable low-cost deposits sustain NIM and avoid expensive wholesale funding; if deposits leave, funding costs rise and margins compress.

    Watch: a rapid, persistent shift of retail or commercial deposits to fintechs or large national banks raising offered rates.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    operating_cash_flow turned positive and grew from 154,193,000 (FY2024) to 390,183,000 (FY2025).

    Open source ↗
  • Growing tangible equity gives Ameris dry powder to pursue accretive M&A or buybacks that lift ROE and EPS, turning balance-sheet expansion into shareholder returns.StrengtheningMateriality: Medium

    stockholders' equity increased from 3,426,747,000 (FY2023) to 3,751,522,000 (FY2024) to 4,076,028,000 (FY2025). If management deploys capital into above-cost-of-capital lending or accretive deals, EPS and returns rise; poor deployment wastes capital and dilutes returns.

    Watch: regulatory capital guidance or stress-test constraints that restrict dividends/repurchases.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    stockholders' equity increased from 3,426,747,000 (FY2023) to 3,751,522,000 (FY2024) to 4,076,028,000 (FY2025).

    Open source ↗
  • If noninterest expense and fee-income trends remain disciplined, Ameris can sustain healthy margins and convert revenue growth into higher returns despite modest funding-cost pressure.HoldingMateriality: Medium

    revenue has trended up from 1,077,872,000 (FY2023) to 1,142,447,000 (FY2024) to 1,207,958,000 (FY2025). Efficiency cushions margin volatility; losing it forces earnings to fall even if revenue grows.

    Watch: step-up in operating expenses from expansion of branches or technology investments that outpace revenue.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    revenue has trended up from 1,077,872,000 (FY2023) to 1,142,447,000 (FY2024) to 1,207,958,000 (FY2025).

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Ameris will continue to translate asset growth and favorable loan/fee pricing into rising GAAP net income provided deposit funding and credit performance remain stable. If true, shareholders get rising earnings and EPS without sacrificing capital; if false, margins and profitability will decay and valuation will compress.

Core deposit stability and prudent liquidity management will fund loan growth and protect margins, which shows up in positive operating cash flow and stable cash balances. Stable low-cost deposits sustain NIM and avoid expensive wholesale funding; if deposits leave, funding costs rise and margins compress.

Growing tangible equity gives Ameris dry powder to pursue accretive M&A or buybacks that lift ROE and EPS, turning balance-sheet expansion into shareholder returns. If management deploys capital into above-cost-of-capital lending or accretive deals, EPS and returns rise; poor deployment wastes capital and dilutes returns.

If noninterest expense and fee-income trends remain disciplined, Ameris can sustain healthy margins and convert revenue growth into higher returns despite modest funding-cost pressure. Efficiency cushions margin volatility; losing it forces earnings to fall even if revenue grows.

All standing thesis claims
Original report summary

it sustains deposit-funded loan growth and preserves net interest margin while using rising book equity to deploy capital (organic lending, M&A, buybacks) to raise ROE and EPS.

Evidence assessed Nov 8, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Ameris Bancorp

Where the evidence on Ameris Bancorp stands: Holding on the latest evidence (Nov 8, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.

Bull case: what the evidence supports

  • Ameris will continue to translate asset growth and favorable loan/fee pricing into rising GAAP net income provided deposit funding and credit performance remain stable.

    sec.gov ↗

  • Core deposit stability and prudent liquidity management will fund loan growth and protect margins, which shows up in positive operating cash flow and stable cash balances.

    sec.gov ↗

  • Growing tangible equity gives Ameris dry powder to pursue accretive M&A or buybacks that lift ROE and EPS, turning balance-sheet expansion into shareholder returns.

    sec.gov ↗

  • If noninterest expense and fee-income trends remain disciplined, Ameris can sustain healthy margins and convert revenue growth into higher returns despite modest funding-cost pressure.

    sec.gov ↗

Bear case: what would count against it

  • large deposit outflows forcing reliance on wholesale funding and higher funding costs (competitive pressure from national banks/fintechs).

    sec.gov ↗

  • a rapid, persistent shift of retail or commercial deposits to fintechs or large national banks raising offered rates.

    sec.gov ↗

  • regulatory capital guidance or stress-test constraints that restrict dividends/repurchases.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Ameris Bancorp

Loading the break-condition record for Ameris Bancorp.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Ameris Bancorp filed an SEC 8-K on 2026-10-22: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Ameris Bancorp filed an SEC 8-K on 2026-07-23: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Other material event.

    Ameris Bancorp filed an SEC 8-K on 2026-06-12: Other material event. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • large deposit outflows forcing reliance on wholesale funding and higher funding costs (competitive pressure from national banks/fintechs).
  • a rapid, persistent shift of retail or commercial deposits to fintechs or large national banks raising offered rates.
  • regulatory capital guidance or stress-test constraints that restrict dividends/repurchases.
  • step-up in operating expenses from expansion of branches or technology investments that outpace revenue.

ABCB news

Loading headlines…

Financial statements

ABCB income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

ABCB: quick answers

Have members of Congress traded ABCB?
Reports made public in the last 90 days disclose 1 trade in ABCB by 1 filer: 1 purchase and 0 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed ABCB trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.